OpGen Touts Technology's Ability to Improve De Novo Assembly, Correct Errors in Finished Genomes

The company has used the technology to find errors in microbial assemblies from the Human Microbiome Project, as well as in finished genomes, and to close introduced gaps in sequenced human genomes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.